BioNeutral (BONU) Inactive 10-Q2011 Q2 Quarterly report

Filed: 14 Jun 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: affinity, allocate, APIC, arise, Asian, attending, attorney, Baltimore, Beach, biological, Broward, Canada, certified, Chairman, CHI, clinical, Commissioner, Commonwealth, compromise, conference, contract, contracted, County, Court, covering, decide, decline, delineated, Department, developmental, diagnosed, dietary, directly, Disabled, disagreement, dispute, disputing, domestic, East, ECT, emerging, employment, endorse, entertainment, Epidemiology, ETA, exact, Exhibit, expand, extremely, final, firm, Florida, forum, gallon, Grayson, handling, higher, Holt, homeland, house, human, incentive, Indemnification, indemnify, India, infection, inKentucky, Internist, introduce, inventoried, inventory, KHA, KHSC, Kingdom, location, MD, medical, Medicine, mentioned, Middle, municipal, Oakland, official, package, page, Palm, partner, pharmaceutical, postponed, practitioner, produce, produced, Professor, program, Proposal, quantify, quickly, ratio, Raymond, receipt, recommend, reconcile, reconciled, reduction, reimburse, released, relocate, remediated, remuneration, rendered, research, resolution, return, RFP, royalty, run, scoring, Searchhelp, serving, ship, shipped, shipping, South, space, spent, Stephen, subscription, supplement, threat, title, University, unprecedented, unregulated, vendor, viable, Vice, weapon, writing

Removed: delivery, iii, iv, work

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BONU similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of BioNeutral Group, Inc. (the “Company”) on Form 10-Q for the period ended April 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen Browand, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

June 14, 2011	/s/ Stephen Browand
	Name:	Stephen Browand
	Title:	Chief Executive Officer (Principal Executive Officer and Principal Financial Officer)